Noticias de ARGX_US

Mercado

Noticias del mercado

Últimas noticias sobre ARGX_US — 353 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ARGX_US ✕ 353 resultados
29/07/2026 ARGX_US — Yahoo Finance
argenx Bets $2.2 Billion on a Vitiligo Breakthrough: What the Forte Biosciences Deal Means for Both Stocks
29/07/2026 ARGX_US — Yahoo Finance
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?
29/07/2026 ARGX_US — careplusvn.com
argenx (ARGX) Shares Edge Higher, Testing Key Resistance Near $927 - Volatility Skew
28/07/2026 ARGX_US — Yahoo Finance
Forte Biosciences (FBRX) Agrees To argenx Takeover As Tender Offer Nears
28/07/2026 ARGX_US — Seeking Alpha
argenx: Upgrading To Buy, The VYVGART Growth Cycle Has Further To Go
27/07/2026 ARGX_US — Bloomberg
Argenx to Buy Forte Biosciences for About $2.2 Billion in Cash
27/07/2026 ARGX_US — GlobeNewswire
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
27/07/2026 ARGX_US — Seeking Alpha
argenx To Acquire Forte Biosciences: What Investors Should Know (NASDAQ:ARGX)
27/07/2026 ARGX_US — Law360
Freshfields-Led Drug Co. To Buy Forte Biosciences For $2.2B
27/07/2026 ARGX_US — Pharmaceutical Executive
argenx Acquires Forte Biosciences for $2.2 Billion
27/07/2026 ARGX_US — Yahoo Finance
Wedbush Raises Price Target on Argenx to $1,050 From $1,000, Maintains Outperform Rating
27/07/2026 ARGX_US — Stock Titan
argenx (Nasdaq: ARGX) to acquire Forte Biosciences in $2.2B cash tender offer
26/07/2026 ARGX_US — Yahoo Finance
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

Página 18 de 18